Researchers have developed an experimental compound that could treat vision loss in premature infants and adults.
List view / Grid view
Filter the results
Dr Sarah Doyle and Dr Ema Ozaki outline their research into SARM1 and why it presents an attractive target for treating retinal degeneration.
Scientists have showed that a three inhibitors (3i) cocktail could reprogramme fibroblasts to a naïve embryonic stem cell-like state and remove disease-associated epigenetic changes.
A team of researchers led by the University of Missouri has employed a mouse model exhibiting diabetic retinopathy symptoms that could lead to future translational research studies.
Targeted interventions can significantly improve screening for diabetic retinopathy, according to a new Cochrane Systematic Review.